---
document_datetime: 2023-09-21 22:22:33
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/thymanax-epar-all-authorised-presentations_en.pdf
document_name: thymanax-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0664366
conversion_datetime: 2025-12-18 08:58:42.585457
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/08/498/002  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 14 tablets  |
| EU/1/08/498/003  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 28 tablets  |
| EU/1/08/498/005  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 56 tablets  |
| EU/1/08/498/006  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 84 tablets  |
| EU/1/08/498/007  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 98 tablets  |
| EU/1/08/498/008  | Thymanax          | 25 mg      | Film coated tablet    | Oral use                  | Blister (alu/PVC)     | 100 tablets |

<!-- image -->